Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 52 (10) , PL79-PL84
- https://doi.org/10.1016/0024-3205(93)90521-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- In Vitro and In Vivo Characteristics of a Heme Oxygenase Inhibitor: ZnBGThe Lancet Healthy Longevity, 1991
- Absorption of Zinc Deuteroporphyrin IX 2,4-Bis-GIycol by the Neonatal Rat Small Intestine in vivoDevelopmental Pharmacology and Therapeutics, 1991
- Oral Administration of Zinc Deuteroporphyrin IX 2,4 Bis Glycol Inhibits Heme Oxygenase in Neonatal RatsDevelopmental Pharmacology and Therapeutics, 1991
- Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrinHepatology, 1989
- Effects of Oral Administration of Tin and Zinc Protoporphyrin on Neonatal and Adult Rat Tissue Heme Oxygenase ActivityJournal of Pediatric Gastroenterology and Nutrition, 1988
- Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humansClinical Pharmacology & Therapeutics, 1986
- Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrinBiochemical Journal, 1985
- Prevention of Neonatal Hyperbilirubinemia in Rhesus Monkeys by Tin-protoporphyrinPediatric Research, 1984
- Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.The Journal of Experimental Medicine, 1982
- Zinc · protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1981